RathiVIyerMD
Pediatric Hematology & Oncology • Jackson, MSProfessor, Pediatrics, University of Mississippi School of Medicine
Dr. Iyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2500 N State St
Jackson, MS 39216Phone+1 601-984-2716
Education & Training
Children's Hospital of MichiganFellowship, Pediatric Hematology/Oncology, 1970 - 1972- Children's Hospital of MichiganResidency, Pediatrics, 1968 - 1970
Osmania Medical College NTR UHSClass of 1966
Certifications & Licensure
MS State Medical License 1973 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia Start of enrollment: 2000 Aug 01
- Effectiveness of Arginine as a Treatment for Sickle Cell Anemia Start of enrollment: 2004 Jun 01
Publications & Presentations
PubMed
- 792 citationsProphylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.Marilyn H. Gaston, Joel Verter, Gerald M. Woods, Charles H. Pegelow, John F. Kelleher
The New England Journal of Medicine. 1986-06-19 - 29 citationsTranscranial doppler ultrasonography (TCD) in infants with sickle cell anemia: Baseline data from the BABY HUG trialSteven G. Pavlakis, Renee C. Rees, Xiangke Huang, R. Clark Brown, James F. Casella
Pediatric Blood & Cancer. 2009-10-07 - 84 citationsBiomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG TrialZora R. Rogers, Winfred C. Wang, Zhaoyu Luo, Rathi V. Iyer, Eglal Shalaby-Rana
Blood. 2011-03-03
Grant Support
- Blood Safety Surveillance Among Persons With Sickle Cell Disease In MississippiCenters For Disease Control And Prevention2012
- Pediatric Hydroxyurea Phase III Clinical TrialDivision Of Blood Diseases And Resources2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
